Becotatug
Product Specifications
CAS Number
2648260-93-7
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||Angiogenesis
Purity
0.991
Bioactivity
Becotatug (JMT101) is a humanised monoclonal antibody targeting EGFR, demonstrating antitumour activity when combined with Osimertinib for treating EGFR-mutated advanced NSCLC.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items